Rimiducid

Generic Name
Rimiducid
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C78H98N4O20
CAS Number
195514-63-7
Unique Ingredient Identifier
H564L1W5J2
Background

Rimiducid is a lipid-permeable tacrolimus analogue and a protein dimerizer. It was designed to overcome limitations of current cellular immunotherapies used for cancer and other blood disorders by enhancing the control of the immune cell activity and function. When administered via chemically-inducible dimerization (CID) technologies, rimiducid binds to switch proteins and dimerizes them, triggering downstream signaling cascade. The combination use of rimiducid with immunotherapies for enhanced therapeutic effectiveness is currently under investigation.

Indication

Investigated for use/treatment in bone marrow transplant and graft versus host disease.

Associated Conditions
-
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath